Laboratorios Richmond SACIF
Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs … Read more
Laboratorios Richmond SACIF (RICH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.003x
Based on the latest financial reports, Laboratorios Richmond SACIF (RICH) has a cash flow conversion efficiency ratio of 0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$202.02 Million) by net assets (AR$72.73 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Laboratorios Richmond SACIF - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Laboratorios Richmond SACIF's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Laboratorios Richmond SACIF Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laboratorios Richmond SACIF ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NEORIGIN Co. Ltd
KQ:094860
|
-0.069x |
|
H-FARM SPA
F:5JQ
|
N/A |
|
Maniker
KO:027740
|
0.165x |
|
CTK Co. Ltd
KQ:260930
|
-0.017x |
|
NextCure Inc
NASDAQ:NXTC
|
-0.265x |
|
Kora Saude Participacoes SA
SA:KRSA3
|
0.020x |
|
Edisun Power Europe AG
SW:ESUN
|
0.008x |
|
Dorel Industries Inc
PINK:DIIBF
|
0.634x |
Annual Cash Flow Conversion Efficiency for Laboratorios Richmond SACIF (2006–2024)
The table below shows the annual cash flow conversion efficiency of Laboratorios Richmond SACIF from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AR$65.35 Billion | AR$5.62 Billion | 0.086x | +194.63% |
| 2023-12-31 | AR$49.98 Billion | AR$-4.54 Billion | -0.091x | +78.32% |
| 2022-12-31 | AR$10.22 Billion | AR$-4.29 Billion | -0.419x | -131.00% |
| 2021-12-31 | AR$5.38 Billion | AR$7.27 Billion | 1.353x | +2622.42% |
| 2020-12-31 | AR$3.38 Billion | AR$-181.33 Million | -0.054x | -193.08% |
| 2019-12-31 | AR$2.10 Billion | AR$121.02 Million | 0.058x | +135.14% |
| 2018-12-31 | AR$1.11 Billion | AR$-182.16 Million | -0.164x | -1109.58% |
| 2017-12-31 | AR$688.05 Million | AR$11.18 Million | 0.016x | +183.82% |
| 2016-12-31 | AR$189.46 Million | AR$-3.67 Million | -0.019x | +92.67% |
| 2015-12-31 | AR$96.12 Million | AR$-25.42 Million | -0.264x | -477.45% |
| 2011-12-31 | AR$50.10 Million | AR$3.51 Million | 0.070x | -62.15% |
| 2010-12-31 | AR$44.82 Million | AR$8.30 Million | 0.185x | +694.54% |
| 2009-12-31 | AR$53.73 Million | AR$1.25 Million | 0.023x | -95.41% |
| 2007-12-31 | AR$13.25 Million | AR$6.73 Million | 0.508x | -69.41% |
| 2006-12-31 | AR$7.75 Million | AR$12.87 Million | 1.661x | -- |